极品新婚夜少妇真紧,亚洲精品一区二区三区中文字幕 ,久久久久人妻精品一区三寸蜜桃,日韩人妻无码一区二区三区

產(chǎn)品資料

ALDH3A2, Blocking Peptide

如果您對(duì)該產(chǎn)品感興趣的話,可以
產(chǎn)品名稱: ALDH3A2, Blocking Peptide
產(chǎn)品型號(hào):
產(chǎn)品展商: 其他品牌
產(chǎn)品文檔: 無(wú)相關(guān)文檔

簡(jiǎn)單介紹

ALDH3A2, Blocking Peptide


ALDH3A2, Blocking Peptide  的詳細(xì)介紹
Product Name

ALDH3A2, Blocking Peptide

Full Product Name

ALDH3A2 Peptide - C-terminal region

Product Gene Name

ALDH3A2 blocking peptide

[Similar Products]
Product Synonym Gene Name
SLS; FALDH; ALDH10; ALDH3A2[Similar Products]
Antibody/Peptide Pairs
ALDH3A2 peptide (MBS3244985) is used for blocking the activity of ALDH3A2 antibody (MBS3220162)
Research Use Only
For Research Use Only. Not for use in diagnostic procedures.
TOP
Sequence
Synthetic peptide located within the following region: GSSGMGAYHG KHSFDTFSHQ RPCLLKSLKR EGANKLRYPP NSQSKVDWGK
OMIM
phenotype 609523
3D Structure
ModBase 3D Structure for P51648
Species Reactivity
Human
Form/Format
Lyophilized powder
Preparation and Storage
Add 100ul of sterile PBS. Final peptide concentration is 1 mg/ml in PBS. For longer periods of storage, store at -20 degree C. Avoid repeat freeze-thaw cycles.
Other Notes
Small volumes of ALDH3A2 blocking peptide vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.
TOP
Related Product Information for
ALDH3A2 blocking peptide
Aldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This gene product catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acid. Mutations in the gene cause Sjogren-Larsson syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene.
Product Categories/Family for ALDH3A2 blocking peptide
Peptide
NCBI/Uniprot data below describe general gene information for ALDH3A2. It may not necessarily be applicable to this product.
NCBI GI #
1706379
NCBI GeneID
224
NCBI Accession #
P51648.1 [Other Products]
UniProt Primary Accession #
P51648 [Other Products]
UniProt Related Accession #
P51648[Other Products]
Molecular Weight
53kDa
TOP
NCBI Official Full Name
Fatty aldehyde dehydrogenase
NCBI Official Synonym Full Names
aldehyde dehydrogenase 3 family member A2
NCBI Official Symbol
ALDH3A2??[Similar Products]
NCBI Official Synonym Symbols
SLS; FALDH; ALDH10
??[Similar Products]
NCBI Protein Information
fatty aldehyde dehydrogenase
UniProt Protein Name
Fatty aldehyde dehydrogenase
UniProt Synonym Protein Names
Aldehyde dehydrogenase 10; Aldehyde dehydrogenase family 3 member A2; Microsomal aldehyde dehydrogenase
Protein Family
Fatty aldehyde dehydrogenase
UniProt Gene Name
ALDH3A2??[Similar Products]
UniProt Synonym Gene Names
ALDH10; FALDH??[Similar Products]
UniProt Entry Name
AL3A2_HUMAN
TOP
NCBI Summary for ALDH3A2
Aldehyde dehydrogenase isozymes are thought to play a major role in the detoxification of aldehydes generated by alcohol metabolism and lipid peroxidation. This gene product catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acid. Mutations in the gene cause Sjogren-Larsson syndrome. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TOP
UniProt Comments for ALDH3A2
ALDH3A2: Catalyzes the oxidation of long-chain aliphatic aldehydes to fatty acids. Active on a variety of saturated and unsaturated aliphatic aldehydes between 6 and 24 carbons in length. Responsible for conversion of the sphingosine 1-phosphate (S1P) degradation product hexadecenal to hexadecenoic acid. Defects in ALDH3A2 are the cause of Sjoegren-Larsson syndrome (SLS). SLS is an autosomal recessive neurocutaneous disorder characterized by a combination of severe mental retardation, spastic di- or tetraplegia and congenital ichthyosis (increased keratinization). Ichthyosis is usually evident at birth, neurologic symptoms appear in the first or second year of life. Most patients have an IQ of less than 60. Additional clinical features include glistening white spots on the retina, seizures, short stature and speech defects. Belongs to the aldehyde dehydrogenase family. 2 isoforms of the human protein are produced by alternative splicing.

Protein type: Carbohydrate Metabolism - propanoate; Amino Acid Metabolism - histidine; Membrane protein, integral; Oxidoreductase; EC 1.2.1.3; Amino Acid Metabolism - lysine degradation; Carbohydrate Metabolism - ascorbate and aldarate; Carbohydrate Metabolism - pyruvate; Carbohydrate Metabolism - butanoate; Other Amino Acids Metabolism - beta-alanine; Lipid Metabolism - fatty acid; Amino Acid Metabolism - arginine and proline; Secondary Metabolites Metabolism - limonene and pinene degradation; Lipid Metabolism - glycerolipid; Carbohydrate Metabolism - glycolysis and gluconeogenesis; Amino Acid Metabolism - tryptophan; Amino Acid Metabolism - valine, leucine and isoleucine degradation; Mitochondrial

Chromosomal Location of Human Ortholog: 17p11.2

Cellular Component: endoplasmic reticulum membrane; intracellular membrane-bound organelle; mitochondrial inner membrane; integral to membrane; peroxisome

Molecular Function: long-chain-alcohol oxidase activity; aldehyde dehydrogenase (NAD) activity; aldehyde dehydrogenase [NAD(P)+] activity; 3-chloroallyl aldehyde dehydrogenase activity; long-chain-aldehyde dehydrogenase activity

Biological Process: phytol metabolic process; epidermis development; central nervous system development; aldehyde metabolic process; sesquiterpenoid metabolic process; peripheral nervous system development

Disease: Sjogren-larsson Syndrome
Research Articles on ALDH3A2
1. Homozygous ALDH3A2 mutations exhibited an unusual neuro-regressive clinical course associated with seizures in Sjogren-Larsson syndrome patients, which may reflect the presence of unidentified genetic or environmental modifiers in this consanguineous population.
TOP
Precautions
All of MyBioSource's Products are for scientific laboratory research purposes and are not for diagnostic, therapeutics, prophylactic or in vivo use. Through your purchase, you expressly represent and warrant to MyBioSource that you will properly test and use any Products purchased from MyBioSource in accordance with industry standards. MyBioSource and its authorized distributors reserve the right to refuse to process any order where we reasonably believe that the intended use will fall outside of our acceptable guidelines.
Disclaimer
While every efforts were made to ensure the accuracy of the information provided in this datasheet, MyBioSource will not be liable for any omissions or errors contained herein. MyBioSource reserves the right to make changes to this datasheet at any time without prior notice.

It is the responsibility of the customer to report product performance issues to MyBioSource within 30 days of receipt of the product. Please visit our Terms & Conditions page for more information.
TOP
TOP
產(chǎn)品留言
標(biāo)題
聯(lián)系人
聯(lián)系電話
內(nèi)容
驗(yàn)證碼
點(diǎn)擊換一張
注:1.可以使用快捷鍵Alt+S或Ctrl+Enter發(fā)送信息!
2.如有必要,請(qǐng)您留下您的詳細(xì)聯(lián)系方式!
相關(guān)產(chǎn)品
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
PDGF-AA, ELISA Kit
Microphthalmia Associated Transcription Factor (MITF), ELISA Kit
microphthalmia-associated transcription factor, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Blocking Peptide
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, Polyclonal Antibody
CYP1B1, cDNA Clone
CYP1B1, Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1, Polyclonal Antibody
Cytochrome P450 1B1, Polyclonal Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1, Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), ELISA Kit
Cytochrome P450 1B1 (CYP1B1), Antibody Pair Kit
Cytochrome P450 1B1 (CYP1B1), Active Protein
Cytochrome P450 1B1 (CYP1B1), Polyclonal Antibody
Cytochrome P450 1B1 (CYP1B1), RTU ELISA Kit
Cytochrome P450 1B1 (CYP1B1), Recombinant Protein
Optineurin, Polyclonal Antibody
AGPAT2, Polyclonal Antibody
AGPAT2, cDNA Clone
AGPAT2, cDNA Clone
AGPAT2, Polyclonal Antibody
AGPAT2, Polyclonal Antibody
AGPAT2, Blocking Peptide
AGPAT2, cDNA Clone

滬公網(wǎng)安備 31011202007343號(hào)